These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29570932)

  • 1. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
    Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
    Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
    Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z
    Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer.
    Huang L; Yu Z; Zhang Z; Ma W; Song S; Huang G
    Sci Rep; 2016 Mar; 6():22449. PubMed ID: 26926077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
    Bourcier C; Griseri P; Grépin R; Bertolotto C; Mazure N; Pagès G
    Am J Physiol Cell Physiol; 2011 Sep; 301(3):C609-18. PubMed ID: 21593445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
    Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
    Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of Tristetraprolin in Tumorigenesis.
    Park JM; Lee TH; Kang TH
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
    Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
    Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
    Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
    Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of AMPKα1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer.
    Han X; Ren C; Yang T; Qiao P; Wang L; Jiang A; Meng Y; Liu Z; Du Y; Yu Z
    Oncogene; 2019 Sep; 38(38):6537-6549. PubMed ID: 31358902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer.
    Yang T; Ren C; Lu C; Qiao P; Han X; Wang L; Wang D; Lv S; Sun Y; Yu Z
    Cancer Res; 2019 Oct; 79(20):5233-5244. PubMed ID: 31409638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
    Yang T; Ren C; Qiao P; Han X; Wang L; Lv S; Sun Y; Liu Z; Du Y; Yu Z
    Oncogene; 2018 Nov; 37(45):5997-6009. PubMed ID: 29985480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.
    Pandiri I; Chen Y; Joe Y; Kim HJ; Park J; Chung HT; Park JW
    Breast Cancer Res Treat; 2016 Feb; 156(1):57-64. PubMed ID: 26956973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.
    Al-Souhibani N; Al-Ahmadi W; Hesketh JE; Blackshear PJ; Khabar KS
    Oncogene; 2010 Jul; 29(29):4205-15. PubMed ID: 20498646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer.
    Lee HH; Son YJ; Lee WH; Park YW; Chae SW; Cho WJ; Kim YM; Choi HJ; Choi DH; Jung SW; Min YJ; Park SE; Lee BJ; Cha HJ; Park JW
    Int J Cancer; 2010 Apr; 126(8):1817-1827. PubMed ID: 19697322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
    Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
    Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways.
    Deleault KM; Skinner SJ; Brooks SA
    Mol Immunol; 2008 Jan; 45(1):13-24. PubMed ID: 17606294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).
    Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T
    Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
    Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
    Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
    Lee SR; Jin H; Kim WT; Kim WJ; Kim SZ; Leem SH; Kim SM
    Int J Oncol; 2018 Sep; 53(3):1269-1278. PubMed ID: 29956753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tristetraprolin: A cytosolic regulator of mRNA turnover moonlighting as transcriptional corepressor of gene expression.
    Rodríguez-Gómez G; Paredes-Villa A; Cervantes-Badillo MG; Gómez-Sonora JP; Jorge-Pérez JH; Cervantes-Roldán R; León-Del-Río A
    Mol Genet Metab; 2021 Jun; 133(2):137-147. PubMed ID: 33795191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.